ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1781

Analysis of Influences of Various Factors on the Prognosis of Acute Confusional State of Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus

Gakuro Abe1, Yoshiyuki Arinuma1, Hirotoshi Kikuchi2 and Shunsei Hirohata1, 1Kitasato University School of Medicine, Sagamihara, Japan, 2Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoantibodies, Magnetic resonance imaging (MRI), neuropsychiatric disorders and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Neuropsychiatric systemic lupus erythematosus (NPSLE), especially diffuse psychiatric/neuropsychological syndromes (diffuse NPSLE), is one of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very useful tool to detect the various abnormalities. We previously disclosed that patients with diffuse NPSLE and MRI abnormalities have more severe inflammation in the central nervous system compared with those without MRI abnormalities, as evidenced by poorer prognosis. Of note, acute confusional state (ACS) is the most recalcitrant manifestation in diffuse NPSLE. However, it remains unclear whether abnormalities in brain MRI still have any influences in patients with ACS. The aim of this study is to explore the influences of various factors, including brain MRI abnormalities, on the prognosis of patients with ACS.

Methods: Thirty-six patients with ACS admitted to our University Hospitals from 1992 to 2015 were exhaustively enrolled in this study. Their medical charts and brain MRI scans were reviewed. The influences of various factors on the mortality of the patients were analyzed.

Results: During the observation periods (33.7}85.4months, mean}SD), 8 of the 36 patients (22.2%) died. The causes of death were related with the disease activity of SLE, mainly NPSLE, in the 8 patients. All the fatal patients died within 8 months from the onset of ACS (3.00}2.97 months, mean}SD). Notably, all these 8 patients presented brain MRI abnormalities, whereas none of the 18 patients without MRI abnormalities died. Accordingly, the presence of brain MRI abnormalities significantly increased the mortality rate in patients with ACS.  To explore in detail the effects of various factors, including MRI abnormalities, on the mortality of patients with ACS, further analysis was carried out using Cox proportional hazards model. As shown in Table, the presence of brain MRI abnormalities, the presence of serum anti-Sm antibodies and serum IL-6 levels significantly increased the risk for mortality in multivariate analysis. 

Conclusion: These results demonstrate that patients with ACS of diffuse NPSLE with MRI abnormalities have more severe diseases, resulting in poorer prognoses. The data also indicate that serum anti-Sm antibodies and serum IL-6 are critical factors influencing the prognosis of patients with ACS. Table

Effects of various factors on the survival in patients with acute confusional state

      Univariate HR (95% CI)* p       Multivariate        HR (95% CI)* p
Age 2.767 (0.205-35.957) 0.4328
Male gender 1.812e-7 (0.722-0.722) 0.0238 1.303e-8 (2.11e-136-0.851) 0.0367
Abnormalities on    MRI scan 1.350e+7 (4.479-4.479) 0.0004 1.904e+9 (8.172-9.669e+24) 0.0013
Serum anti-Sm 2.486 (0.573-16.963) 0.2349 6.565e+16 (7.027-4.787e+55) 0.0167
Serum IL-6 1.001 (0.9998-1.002) 0.0742 6.01e+17 (30.039-9.42e+56)) 0.0070
CSF IL-6 0.193 (8.44e-15-9.409) 0.6127 1.732e-9 (3.54e-42-1.32e+16) 0.1749


Disclosure: G. Abe, None; Y. Arinuma, None; H. Kikuchi, None; S. Hirohata, None.

To cite this abstract in AMA style:

Abe G, Arinuma Y, Kikuchi H, Hirohata S. Analysis of Influences of Various Factors on the Prognosis of Acute Confusional State of Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/analysis-of-influences-of-various-factors-on-the-prognosis-of-acute-confusional-state-of-diffuse-psychiatricneuropsychological-syndromes-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-influences-of-various-factors-on-the-prognosis-of-acute-confusional-state-of-diffuse-psychiatricneuropsychological-syndromes-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology